Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases

The aim of the study was to study the efficacy, safety and immunogenicity of trivalent split influenza vaccine in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), systemic scleroderma (SSD). Material and methods. Ninety three patients were enrolled in the study, including 52 pat...

Full description

Bibliographic Details
Main Authors: D. V. Bukhanova, B. S. Belov, G. M. Tarasova, Sh. Erdes, T. V. Dubinina, G. V. Lukina, N. V. Demidova, A. V. Volkov, N. N. Yudkina, M. V. Cherkasova, M. E. Diatroptov
Format: Article
Language:Russian
Published: Remedium Group LLC 2018-07-01
Series:Медицинский совет
Subjects:
rheumatoid arthritis
ankylosing spondylitis
autoimmune diseases
comorbid infections
comorbidity
influenza
vaccination
flu vaccine
Online Access:https://www.med-sovet.pro/jour/article/view/2572

Internet

https://www.med-sovet.pro/jour/article/view/2572

Similar Items